Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Daxor Corp (DXR)

Daxor Corp (DXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center GlobeNewswire - Wed Apr 8, 7:00AM CDT

Oak Ridge, TN, April 08, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, continues its strategic expansion with the launch of a...

DXR : 9.53 (+1.60%)
Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 GlobeNewswire - Thu Mar 26, 7:00AM CDT

OAK RIDGE, TN, March 26, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces that new clinical data evaluating the accuracy...

DXR : 9.53 (+1.60%)
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions GlobeNewswire - Tue Mar 17, 7:00AM CDT

Oak Ridge, TN, March 17, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR) , the global leader in blood volume measurement technology, today announces its participation as an exhibitor at...

DXR : 9.53 (+1.60%)
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress GlobeNewswire - Tue Mar 10, 7:00AM CDT

Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay Oak Ridge, TN, March 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR) , the global...

DXR : 9.53 (+1.60%)
Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026 ACCESS Newswire - Tue Mar 10, 4:00AM CDT

RALEIGH, NC / ACCESS Newswire / March 10, 2026 / iAccess Alpha's Virtual Best Ideas Spring Investment Conference will take place on March 10-11, 2026, bringing together a curated group of public companies...

CJMB : 1.1400 (+4.59%)
ELWT : 6.45 (+5.39%)
LODE : 3.10 (+1.97%)
FLNT : 3.35 (+5.35%)
SKYX : 1.1450 (-2.14%)
BCHT : 1.8450 (+2.50%)
OMEX : 1.1100 (-5.13%)
DHX : 2.96 (+3.86%)
GSIT : 6.25 (-0.56%)
AMNF : 10.2932 (-1.20%)
CITR : 8.64 (-2.15%)
NTWK : 3.42 (-1.16%)
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 GlobeNewswire - Mon Mar 9, 7:00AM CDT

Oak Ridge, TN, March 09, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces that CEO and President Michael Feldschuh will...

DXR : 9.53 (+1.60%)
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders GlobeNewswire - Tue Mar 3, 7:30AM CST

Oak Ridge, TN, March 03, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology today issued a corporate update in a Letter to Shareholders...

DXR : 9.53 (+1.60%)
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share GlobeNewswire - Tue Mar 3, 7:00AM CST

Strategic Realignment to Clinical Growth Supported by FDA 510(k) Clearance for Next-Generation Blood Volume Analyzer Oak Ridge, TN, March 03, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:...

DXR : 9.53 (+1.60%)
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee GlobeNewswire - Tue Feb 24, 7:00AM CST

Expansion Leverages Daxor’s ezBVA Lab to Deliver 98% Accurate Diagnostics with Zero Capital Investment  Oak Ridge, TN, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR),...

DXR : 9.53 (+1.60%)
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business GlobeNewswire - Tue Feb 10, 7:00AM CST

Oak Ridge, TN, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announced its intention to transition its primary...

DXR : 9.53 (+1.60%)

Barchart Exclusives

Unusual Kraft Heinz Options Trading Shows Investors Are Nervous Before Earnings Barchart - 31 minutes ago
Unusual volume in at-the-money call options of The Kraft Heinz Company today shows investors may be nervous ahead of earnings. Will KHC's free cash flow and margins rise after the CEO turned down a split? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.